|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
24.09.25 - 14:06
|
TruTechnologies Appoints Mirador Therapeutics Executive Jordan Zwick to Board of Directors (Business Wire)
|
|
|
DURHAM, N.C.--(BUSINESS WIRE)--#ClinicalResearch--TruTechnologies, a leading provider of real-time clinical trial oversight, today announced Jordan Zwick joined its Board of Directors, bringing extensive experience in corporate strategy and business development to the Company.
Jordan Zwick is Chief Business Officer and a founding team member at Mirador Therapeutics. He previously served as a strategic advisor to Prometheus Biosciences prior to its acquisition by Merck in 2023. He is on the Board of Directors of Theratechnologies Inc., where he played a central role in its recently announced acquisition by Future Pak.
Earlier in his career, Mr. Zwick played a key role in the $14.5 billion sale of Salix Pharmaceuticals to what is now Bausch Health Companies in 2015. Post-sale, he went on to serve as Head of Strategy for the Salix business unit, overseeing business development, strategic partnerships and portfolio management. Throughout his career, Jordan has led capital raises, alliances and transactions, a...
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
21.08.25 - 14:18
|
Bausch Health Companies Inc.: Bausch Health, Canada Inc. Treatment for Acne Vulgaris, CABTREO, Now Available Through Public Drug Plans of Quebec and Saskatchewan (Accesswire)
|
|
|
LAVAL, QC / ACCESS Newswire / August 21, 2025 / Bausch Health, Canada Inc., part of Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC), a global, diversified pharmaceutical company, today announced t......
|
|
|
18.08.25 - 23:06
|
Bausch + Lomb Announces Board Changes (Business Wire)
|
|
|
VAUGHAN, Ontario--(BUSINESS WIRE)--Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced that the Amended and Restated Director Appointment and Nomination Agreement, dated as of June 21, 2022, by and among the company and Mr. Carl C. Icahn and certain of his affiliates, terminated pursuant to its terms when the Icahn group's net long position in the common shares of Bausch + Lomb's parent company, Bausch Health Companies Inc., fell below the required threshold. In connection with the termination, Brett M. Icahn and Gary Hu have resigned from the Bausch + Lomb Board of Directors.
“I appreciate Brett and Gary's valuable contributions to the company over the past three years, and wish them well going forward,” said Brent Saunders, chairman and CEO, Bausch + Lomb.
About Bausch + Lomb
Bausch + Lomb is dedicated to protecting and enhancing the gift of sight for millions of people around the world – from bir...
|
|
|
|
|
|
Börsentreff auf Facebook |
Börsentreff auf X |
Börsentreff auf Instagram
